Clinical Trials on Cytomegalovirus Infection Reactivation

Total 61122 results

Jun Zhang
National Natural Science Foundation of China; Merck Sharp & Dohme LLC

Completed

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

Congenital Cytomegalovirus Infection | Cytomegalovirus Infection Reactivation

China
Anhui Provincial Hospital

Recruiting

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Cytomegalovirus Infection Reactivation

China
SL VAXiGEN
SL BIGEN

Unknown

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

BK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus Reactivation

Korea, Republic of
Hebei Yanda Ludaopei Hospital
China Immunotech (Beijing) Biotechnology Co., Ltd.

Completed

CMV-TCR-T Cells for CM Virus Infection After HSCT

CMV Infection or Reactivation After Allogenic HSCT

China
Siriraj Hospital

Not yet recruiting

The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen (CMV)

CMV Infection or Reactivation After Allogenic HSCT
New York Medical College

Recruiting

CMV CTLs in Neonates With CMV Infection

Congenital Cytomegaloviral (CMV) Disease

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Hematopoietic Cell Transplant Recipient | Cytomegaloviral Infection

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphoid System Neoplasm | Cytomegaloviral Infection

United States
Merck Sharp & Dohme LLC

Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Cytomegalovirus Infection

United States, France, Germany, Italy, Japan, United Kingdom
The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) (CMV)

Congenital Cytomegalovirus Infection | Maternal Cytomegalovirus Infection

United States
Merck Sharp & Dohme LLC

Completed

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

Cytomegalovirus Infection | Cytomegalovirus Disease

Japan
National Institute of Allergy and Infectious Diseases...

Terminated

Asymptomatic Congenital CMV Treatment

Congenital Cytomegalovirus Infection

United States
Institut Pasteur

Completed

Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV (INFECSMELL)

Congenital Cytomegalovirus Infection

France
Assistance Publique - Hôpitaux de Paris

Completed

Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening (CymeAudit)

Congenital Cytomegalovirus Infection

France
Foundation IRCCS San Matteo Hospital
Fondazione Regionale per la Ricerca Biomedica (FRRB) - Regione Lombardia

Unknown

Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy (CHILd)

Congenital Cytomegalovirus Infection | Maternal Cytomegalovirus Infection

Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Cytomegaloviral Infection

United States
Jun Zhang

Completed

A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China

Congenital Cytomegalovirus Infection

China
Assistance Publique - Hôpitaux de Paris

Completed

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir (CYMEVAL2)

Foetuses Infection | Cytomegalovirus (CMV)Infection

France
Mayo Clinic

Completed

A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.

Cytomegalovirus Infection

United States
Assistance Publique - Hôpitaux de Paris

Terminated

In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir (CYMEVAL)

Cytomegalovirus Infection | Viral Disease

France
Assistance Publique - Hôpitaux de Paris

Completed

Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero (CYMEPEDIA)

Congenital Cytomegalovirus Infection

France
Rabin Medical Center

Completed

Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy

Congenital Cytomegalovirus Infection

Israel
National Institute of Allergy and Infectious Diseases...

Completed

A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

Cytomegalovirus Infections

United States
ModernaTX, Inc.

Withdrawn

A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Enrolling by invitation

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Congenital Cytomegalovirus Infection
Virginia Commonwealth University
Vical

Withdrawn

Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine (CM04-101)

Congenital Cytomegalovirus Infection
Biotest

Active, not recruiting

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) (PreCyssion)

Congenital Cytomegalovirus Infection

Germany
Central Hospital, Nancy, France

Completed

Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk

Congenital Cytomegalovirus Infection

France
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
ModernaTX, Inc.

Completed

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Completed

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection

United States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
Assistance Publique Hopitaux De Marseille

Completed

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

Cytomegalovirus Infection

France
Washington University School of Medicine
Hoffmann-La Roche

Completed

Study of Prophylactic Vs Preemptive Valganciclovir

Cytomegalovirus Infection

United States
Hookipa Biotech GmbH

Completed

A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

Kidney Transplantation | Cytomegalovirus (CMV) Infection

United States, Denmark, Norway, United Kingdom, Germany, France
Merck Sharp & Dohme LLC

Completed

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Cytomegalovirus (CMV) Infection

United States, Australia, Colombia, France, Germany, Israel, Japan, Mexico, Poland, Spain, Turkey
Tel-Aviv Sourasky Medical Center

Unknown

Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection

Disorder of Cardiac Function
National Institute of Allergy and Infectious Diseases...

Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Cytomegalovirus Infection

United States
Shire

Completed

Maribavir for Prevention of CMV After Stem Cell Transplants

Cytomegalovirus Infection

United States
Cell Medica Ltd
University of Birmingham; Leukaemia Lymphoma Research; National Health Service...

Completed

Alternate Donor Study of Pre-Emptive Cellular Therapy (CMV-ACE/ASPECT)

Cytomegalovirus Infection

United Kingdom
University of California, San Francisco
Vical

Completed

Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge

Cytomegalovirus Infection

United States
University of California, San Francisco
Vical

Completed

Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM

Cytomegalovirus Infection
ModernaTX, Inc.

Completed

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Cytomegalovirus Infection

United States
Hookipa Biotech GmbH
Centre for Vaccinology Ghent - CEVAC

Completed

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Cytomegalovirus Infection

Belgium
PETHEMA Foundation

Completed

TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant

Cytomegalovirus Infection

Spain
Cell Medica Ltd
Wellcome Trust; EMAS Pharma; Commitum AB; BioAnaLab

Completed

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study (CMV-IMPACT)

Cytomegalovirus Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers

Cytomegalovirus Infection

United States
Lophius Biosciences GmbH
German Federal Ministry of Education and Research

Completed

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients (AlloProtectCMV)

Cytomegalovirus Infection | GVHD

Germany

Clinical Trials on Cytomegalovirus Infection Reactivation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations